Transdermal immunotherapy: Past, present and future

被引:8
|
作者
Szczepanik, Marian [1 ]
Majewska-Szczepanik, Monika [1 ]
机构
[1] Jagiellonian Univ, Dept Med Biol, Coll Med, Krakow, Poland
关键词
Epicutaneous immunization; Immunopotentiation; Allergy; Autoimmunity; Contact sensitivity; SKIN-INDUCED SUPPRESSION; EPICUTANEOUS EC IMMUNIZATION; ANTIGEN TNP-IG; T-CELLS; PROTEIN ANTIGEN; MULTIPLE-SCLEROSIS; SUBLINGUAL IMMUNOTHERAPY; CONTACT HYPERSENSITIVITY; RESIDENT; TOLERANCE;
D O I
10.1016/j.pharep.2016.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human skin plays an important role in thermal regulation, the maintenance of the correct water and electrolyte balance; it is also the main source of the vitamin D for the organism. Moreover, the skin forms an effective barrier against microorganisms, protecting the organism against xenobiotics and harmful external factors. It must also be mentioned that the skin is an essential organ involved in immunological mechanisms. This article summarizes current knowledge about skin-induced suppression induced via epicutaneous (EC) application of an antigen and is described in both Th1- and Tc1-mediated contact sensitivity (CS) in mice. The skin-induced suppression is also considered in the regulation of experimental models of autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE), collagen-induced arthritis (CIA) and colitis ulcerosa. Furthermore, the efficacy of treatment of multiple sclerosis (MS) patients with EC immunization is discussed. Second part of this review introduces new subject of immunopotentiation induced via EC immunization with an antigen in the presence of various pathogen-associated molecular patterns (PAMPs). Finally, the review describes dermal immunization in the therapy of allergic diseases. (C) 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
引用
收藏
页码:773 / 781
页数:9
相关论文
共 50 条
  • [1] Transdermal immunotherapy: Past, present and future
    Marian Szczepanik
    Monika Majewska-Szczepanik
    [J]. Pharmacological Reports, 2016, 68 : 773 - 781
  • [2] Transdermal patches: past, present and future
    Miller, Ken
    [J]. THERAPEUTIC DELIVERY, 2015, 6 (06) : 639 - 641
  • [3] Immunotherapy: past, present and future
    Thomas A. Waldmann
    [J]. Nature Medicine, 2003, 9 : 269 - 277
  • [4] Immunotherapy: past, present and future
    Waldmann, TA
    [J]. NATURE MEDICINE, 2003, 9 (03) : 269 - 277
  • [5] IMMUNOTHERAPY, PAST, PRESENT AND FUTURE
    CHOY, EHS
    KINGSLEY, GH
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (02): : 89 - 91
  • [6] IMMUNOTHERAPY - PAST, PRESENT, AND FUTURE
    NORMAN, PS
    [J]. PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, 1989, : 367 - 373
  • [7] Transdermal drug delivery: Past, present, future
    Scheindlin, S
    [J]. MOLECULAR INTERVENTIONS, 2004, 4 (06) : 308 - 312
  • [8] Allergen immunotherapy: past, present and future
    Durham, Stephen R.
    Shamji, Mohamed H.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2023, 23 (05) : 317 - 328
  • [9] Allergen Immunotherapy: Past, Present, and Future
    Jutel, Marek
    Kosowska, Anna
    Smolinska, Sylwia
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2016, 8 (03) : 191 - 197
  • [10] Cancer immunotherapy: The past, the present and the future
    Parish, CR
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (02): : 106 - 113